New coating for implants, medical devices cuts infection risk
29 April, 2022Infections after hip replacements and from orthopaedic device procedures can be complicated and lead to painful and repeat surgeries.
Drug-resistant environmental mould causes lung infections
27 April, 2022Drug-resistant mould is spreading from the environment and infecting susceptible people's lungs, reveals a new study led by Imperial College London.
Proposal for assessing long COVID patients
26 April, 2022A new assessment proposal aimed at clinicians and researchers hopes to help to establish an individualised treatment protocol for long COVID patients.
Delta variant's invasion trick to evade immune response
21 April, 2022COVID-19's Delta variant may use a novel invasion method to evade the body's immune response, causing damage to the brain, intestine and kidneys, a Griffith University study has found.
Meningitis vaccines could help tackle untreatable gonorrhoea
13 April, 2022Latest studies from South Australia and the US have indicated that meningitis vaccines could help improve protection against gonorrhoea.
UTIs are becoming more deadly, thanks to AMR — CSIRO
06 April, 2022The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs) — which affect around one in two women and one in 20 men in their lifetime.
How can air purifiers help aged care facilities protect residents and staff from harmful viruses?
28 March, 2022 by Kate Smith, Head of Clinical Solutions, Training and Support – GAMA Healthcare (RN/RM, GCertNurs, Cert IV TAE)As winter approaches, with its associated colds and flu, many aged care and long term care facilities will be looking for additional methods to protect their residents and staff.
COVID-19 taskforce publishes new risk classification tool
21 March, 2022The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.
How antimicrobial resistance spreads inside the human gut
21 March, 2022A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.
Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
Mild COVID-19 linked to changes in brain structure: study
09 March, 2022New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.
2022 influenza control: virologist recommends four actions
09 March, 2022With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.
Hepatitis B: new recommendations for clinicians
07 March, 2022New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.
COVID-19 antiviral available on the PBS
02 March, 2022Australians at risk of progressing to severe COVID-19 disease will now be eligible to access an oral antiviral treatment through the PBS.
Ultrasound infection prevention workflow: standardisation unlocking risk management
01 March, 2022Discover how Nanosonics AuditPro can standardise your ultrasound IP practices.
